buy y0ur bl0ck of st0ck today! ...DGCP...

[Kathy Stein]

*DGCP*
Trading at $0.40 a share…..
        Average daily volume of 680 over the past 3-months…..
        Daily volume today (5/02) of 22,000
         INVESTORS... confidence in this company is increasing by the moment…  
Invest now and make cash!!
        :Diagnostic: Corporation of America is in the process of obtaining 
outpatient ...Diagnostic... healthcare facilities in the hopes of merging a 
number of these facilities into a single network, offering superior expertise 
and efficiency in the medical field.  Once again revolutionizing the medical 
industry, DGCP! is likely to become America’s leading suppliers of X (Digital 
Motion XRay) within the coming months.
        The medical industry is only growing larger and the once-smaller 
companies are taking the opportunity to increase their bottom-line and enter 
into direct competition with the chain medical supply stores.  This company is 
prepared to meet the demands of the ever-changing 21st century with their 
%EXPERTISE, our technological superiority over our competitors and our 
willingness to compete.
        Investing in the M now, while still low, assures likely profits over 
time  Buy low, sell high in this %LOW_RISK investment!!!!
IMMEDIATE RELEASE - INVESTOR ALERT

Disclaimer
Statements contained in this release that are not strictly historical are 
``forward-looking'' statements within the meaning of Section 27A of the 
Securities Act of 1933 as amended, and Section 21E of the Securities Exchange 
Act of 1934, as amended. The forward-looking statements are made based on 
information available as of the date hereof, and the company assumes no 
obligation to update such forward-looking statements. Editors and investors are 
cautioned that such forward-looking statements invoke risk and uncertainties 
and the company's actual results may differ from these forward-looking 
statements. Such risks and uncertainties include but are not limited to demand 
for the company's products and services, our ability to continue to develop 
markets, general economic conditions, our ability to secure additional 
financing for the company and other factors that may be more fully described in 
reports to shareholders and periodic filings with the Securities and Exchange 
Commission.